Balyasny Asset Management L.P. grew its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 16.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 558,289 shares of the company's stock after buying an additional 78,123 shares during the quarter. Balyasny Asset Management L.P. owned 1.99% of Establishment Labs worth $25,720,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Capital Research Global Investors lifted its stake in shares of Establishment Labs by 29.3% in the 4th quarter. Capital Research Global Investors now owns 1,911,525 shares of the company's stock valued at $88,064,000 after purchasing an additional 433,484 shares during the last quarter. Voya Investment Management LLC boosted its stake in Establishment Labs by 7,249.5% during the fourth quarter. Voya Investment Management LLC now owns 408,262 shares of the company's stock worth $18,809,000 after buying an additional 402,707 shares during the period. Assenagon Asset Management S.A. bought a new position in Establishment Labs during the fourth quarter valued at $12,898,000. Bamco Inc. NY increased its position in Establishment Labs by 53.8% during the fourth quarter. Bamco Inc. NY now owns 752,886 shares of the company's stock valued at $34,685,000 after acquiring an additional 263,500 shares during the last quarter. Finally, William Blair Investment Management LLC raised its stake in shares of Establishment Labs by 44.1% in the fourth quarter. William Blair Investment Management LLC now owns 812,825 shares of the company's stock valued at $37,447,000 after acquiring an additional 248,888 shares during the period. Hedge funds and other institutional investors own 72.91% of the company's stock.
Analyst Upgrades and Downgrades
A number of analysts recently weighed in on ESTA shares. Needham & Company LLC initiated coverage on shares of Establishment Labs in a research report on Monday, April 14th. They issued a "hold" rating on the stock. Stephens reiterated an "overweight" rating and issued a $52.00 price target on shares of Establishment Labs in a report on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $57.40.
Check Out Our Latest Stock Analysis on Establishment Labs
Establishment Labs Stock Performance
Shares of NASDAQ:ESTA opened at $33.08 on Wednesday. The firm's 50 day simple moving average is $35.43 and its 200-day simple moving average is $38.73. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62. Establishment Labs Holdings Inc. has a one year low of $26.56 and a one year high of $60.12. The firm has a market cap of $954.11 million, a PE ratio of -12.82 and a beta of 0.73.
Establishment Labs (NASDAQ:ESTA - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing the consensus estimate of ($0.64) by ($0.34). Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The firm had revenue of $44.51 million for the quarter, compared to analysts' expectations of $44.45 million. As a group, equities analysts predict that Establishment Labs Holdings Inc. will post -2.41 EPS for the current year.
Establishment Labs Profile
(
Free Report)
Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.
Featured Articles
Want to see what other hedge funds are holding ESTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Establishment Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Establishment Labs wasn't on the list.
While Establishment Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
